CD274 and neoplasm: By combining biochemical, computational, and microscopy approaches with label-free monitoring of T-cell activation, we provide the first evidence that the dietary polyphenol resveratrol (RSV) can directly target PD-L1 glycosylation and dimerization to enhance anti-tumor T-cell immunity.